124 related articles for article (PubMed ID: 18310900)
1. Chemoprevention of tumor metastasis by liposomal beta-sitosterol intake.
Imanaka H; Koide H; Shimizu K; Asai T; Kinouchi Shimizu N; Ishikado A; Makino T; Oku N
Biol Pharm Bull; 2008 Mar; 31(3):400-4. PubMed ID: 18310900
[TBL] [Abstract][Full Text] [Related]
2. Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol.
Hasegawa H; Suzuki R; Nagaoka T; Tezuka Y; Kadota S; Saiki I
Biol Pharm Bull; 2002 Jul; 25(7):861-6. PubMed ID: 12132658
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.
Smyth MJ; Taniguchi M; Street SE
J Immunol; 2000 Sep; 165(5):2665-70. PubMed ID: 10946296
[TBL] [Abstract][Full Text] [Related]
4. Effects of Chinese medicinal fungus water extract on tumor metastasis and some parameters of immune function.
Zhang W; Wang Y; Hou Y
Int Immunopharmacol; 2004 Mar; 4(3):461-8. PubMed ID: 15037223
[TBL] [Abstract][Full Text] [Related]
5. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
Grundy MA; Zhang T; Sentman CL
Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
[TBL] [Abstract][Full Text] [Related]
6. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
7. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
8. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice.
Spitzer JH; Núñez NP; Meadows SA; Gallucci RM; Blank SE; Meadows GG
Alcohol Clin Exp Res; 2000 Jun; 24(6):837-44. PubMed ID: 10888072
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.
Turner JG; Rakhmilevich AL; Burdelya L; Neal Z; Imboden M; Sondel PM; Yu H
J Immunol; 2001 Jan; 166(1):89-94. PubMed ID: 11123280
[TBL] [Abstract][Full Text] [Related]
10. [Effect of beta-sitosterol incorporated into liposomes on several indicators of lipid metabolism in experimental hypercholesteremia in rats].
Datsenko ZM; Kholodova IuD; Kokunin VA; Klimashevskiĭ VM; Peredereĭ OF
Vopr Med Khim; 1984; 30(6):33-8. PubMed ID: 6528535
[TBL] [Abstract][Full Text] [Related]
11. Liposomal Arg-Gly-Asp analogs effectively inhibit metastatic B16 melanoma colonization in murine lungs.
Oku N; Tokudome Y; Koike C; Nishikawa N; Mori H; Saiki I; Okada S
Life Sci; 1996; 58(24):2263-70. PubMed ID: 8649213
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
Jin GH; Hirano T; Murakami M
Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles.
Goldfarb RH; Kitson RP; Brunson KW; Yoshino K; Hirota N; Kirii Y; Kotera Y; Inoue Y; Ohashi M
Anticancer Res; 1999; 19(3A):1663-7. PubMed ID: 10470098
[TBL] [Abstract][Full Text] [Related]
15. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge.
Krishnan L; Sad S; Patel GB; Sprott GD
Cancer Res; 2003 May; 63(10):2526-34. PubMed ID: 12750276
[TBL] [Abstract][Full Text] [Related]
16. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis].
Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of liposomal IL1 alpha and TNF alpha against the pulmonary metastases of the B16F10 murine melanoma in syngeneic mice.
Saito M; Fan D; Lachman LB
Clin Exp Metastasis; 1995 Jul; 13(4):249-59. PubMed ID: 7606887
[TBL] [Abstract][Full Text] [Related]
18. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
Lala PK; Parhar RS
Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954
[TBL] [Abstract][Full Text] [Related]
19. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
20. Targeting and anti-tumor efficacy of liposomal 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in mice lung bearing B16BL6 melanoma.
Asai T; Shuto S; Matsuda A; Kakiuchi T; Ohba H; Tsukada H; Oku N
Cancer Lett; 2001 Jan; 162(1):49-56. PubMed ID: 11121862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
